U-Blot® Research Grade MasavibartCat. No. WA3136$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade MasavibartCat. No. WA3136
U-Blot® Research Grade MarstacimabCat. No. WA3135
U-Blot® Research Grade MaridebartCat. No. WA3134
U-Blot® Research Grade MargetuximabCat. No. WA3133
U-Blot® Research Grade MapatumumabCat. No. WA3132
U-Blot® Research Grade ManfidokimabCat. No. WA3131
U-Blot® Research Grade ManelimabCat. No. WA3130
U-Blot® Research Grade MagrolimabCat. No. WA3129
U-Blot® Research Grade MaftivimabCat. No. WA3128
U-Blot® Research Grade M802Cat. No. WA3127
U-Blot® Research Grade LY3022855Cat. No. WA3126
U-Blot® Research Grade LY3016859Cat. No. WA3125